In tumor cells, it has been demonstrated that FGF19 can activate downstream signaling pathways, including the FGFR4-ERK pathway, to promote the expression of key enzymes involved in fatty acid synthesis, such as FASN and ACC. This evidence concerns the gene FGFR4 and neoplasm.